Technologies
NanoM Wafer
Sustained Release Technology
The NanoM Wafer is an electrospun sustained-release or immediate-release drug delivery system with proprietary compositions that are:
-
bioadhesive to mucosa
-
biocompatible
-
porous (mimics mucosa) (see image below)
-
rapidly hydrating---integrating with mucosa as drug is released
-
hydrogel - forming after hydration (see image below)
-
can contain multiple drugs with modulated rates of release
-
being developed for "front-of-the-eye" ophthalmic applications to efficiently administer medications to target site (see image for method of use)
-
small < 6 mm in diameter (see image below)
-
Applications for other routes in-development (Women's Health, Transcutaneous, Urological)
OcuSurf Lipid Nanoparticles
Enhance bioavailability through higher membrane permeation
OcuSurf LNP delivery system :
-
Are lipid nanoparticles "nanocores" that are liquid-crystalline (ordered internal microstructure, see microscopy images)
-
Particle size, lipid composition and surface characteristics enhance rapid permeation of formulation into interstices of skin and other lipid structures
-
Nano-size promotes mucosa penetration (see figure below)
-
Once inside, nano-cores melt and release drug
-
APIs that demonstrate low bioavailability are great candidates
-
Nano-core size (<200 nm) penetrates the hair follicles of the eye-lid margin
-
Being developed for ophthalmic, dermal and follicullar indications
-
Fully patented in 12 global jurisdictions
-
505b2 regulatory strategy